Cartilage regeneration aims for FDA approval

Israeli bone regeneration biotech CartiHeal has raised $18.3 million to fund a trial that will help it achieve US FDA approval for its cartilage regeneration technology.  CartiHeal already has CE (European) marketing approval.

http://www.globes.co.il/en/article-israel-bone-regeneration-co-cartiheal-raises-183m-1001187527

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *